Altamira Therapeutics Ltd
CYTO
CYTO was delisted on the 19th of December, 2024.
5 hedge funds and large institutions have $531K invested in Altamira Therapeutics Ltd in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, reducing their positions, and 7 closing their positions.
155% more capital invested
Capital invested by funds: $208K → $531K (+$323K)
50% less funds holding
Funds holding: 10 → 5 (-5)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$537K |
| 2 |
Morgan Stanley
New York
|
+$99K |
| 3 |
VF
Virtu Financial
New York
|
+$71.2K |
| 4 |
Jane Street
New York
|
+$46.9K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$17.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$31K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$26K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$25K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$10K |
| 5 |
CGA
Crescent Grove Advisors
Lake Forest,
Illinois
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $342K | +$537K | +309 | New |
|
|
2
Morgan Stanley
New York
| $70K | +$99K | +57 | +950% |
|
|
VF
3
Virtu Financial
New York
| $54K | +$71.2K | +41 | +513% |
|
|
WS
4
Wedbush Securities
Los Angeles,
California
| $35K | +$17.4K | +10 | +48% |
|
|
5
Jane Street
New York
| $30K | +$46.9K | +27 | New |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| – | -$31K | -11 | Closed |
|
|
TSS
7
Two Sigma Securities
New York
| – | -$26K | -10 | Closed |
|
|
8
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$25K | -9 | Closed |
|
|
9
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$10K | -4 | Closed |
|
|
CGA
10
Crescent Grove Advisors
Lake Forest,
Illinois
| – | -$7K | -3 | Closed |
|
|
SPC
11
Sigma Planning Corp
Ann Arbor,
Michigan
| – | -$6K | -2 | Closed |
|
12
UBS Group
Zurich,
Switzerland
| – | -$6K | -2 | Closed |
|
CYTO Hedge Fund Activity: Q2 2019 in Review
5 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q2 2019, worth a combined $531K — up 155% from $208K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CYTO and 2 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 3 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $537K. The largest seller was Geode Capital Management, exiting entirely with an estimated $31K sold.
- 5 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q2 2019, down from 10 in Q1 2019.
- Funds reported $531K of Altamira Therapeutics Ltd stock for Q2 2019, up 155% quarter-over-quarter.
- 2 funds opened new Altamira Therapeutics Ltd positions in Q2 2019 and 7 closed out, a net change of -5 holders.
- The largest Altamira Therapeutics Ltd buyer in Q2 2019 was Sabby Management, an estimated $537K added.
- The largest Altamira Therapeutics Ltd seller in Q2 2019 was Geode Capital Management, an estimated $31K sold.
Based on aggregated 13F filings for Q2 2019.